Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. Archives of Pediatric Infectious Diseases
  4. Articles

  5. Successful Treatment of Carbapenem-Resistant Klebsiella pneumoniae Meningitis with Combination Therapy of Meropenem and Amikacin
  6. Crossref

Archives of Pediatric Infectious Diseases

The Official Journal of Pediatric Infections Research Center, SBMU

homeHome
check_circleAccepted Manuscriptsplay_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn PresssearchSearch
settingsInstructions
articleJournal InformationgroupsEditors & BoardsshareIndexing and Listing SourcesbalancePublication Ethics and Malpractice StatementemailSupportshow_chartJournal MetricsphoneContact Usassignment_indReviewer and AE Registration Formzoom_inOpen Peer Review (OPR)
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Crossref


1. Clinical characteristics and antimicrobial therapy of healthcare-associated carbapenem-non-susceptible gram-negative bacterial meningitis: a 16-year retrospective cohort study

- Jiyan Xu

- Xiaoling Du

- Dan Li

- Pei Li

- Qinglan Guo

- Xiaogang Xu

- Fupin Hu

- Minggui Wang

HomeInstructionsAPC

Articles

  • Accepted Manuscripts
  • Current Issue
  • All Issues
  • In Press
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Publication Ethics and Malpractice Statement
  • Support
  • Journal Metrics
  • Contact Us
  • Reviewer and AE Registration Form
  • Open Peer Review (OPR)
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.